Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-06 10:03 am Purchase |
2025-05-30 | 13G | Seres Therapeutics, Inc. MCRB |
FMR LLC | 493,608 5.700% |
493,608 (New Position) |
Filing History |
| 2025-02-12 09:22 am Purchase |
2024-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
FMR LLC | 1,090,585 12.800% |
121,156 (+12.50%) |
Filing History |
| 2024-10-02 08:15 am Purchase |
2024-09-30 | 13D | Seres Therapeutics, Inc. MCRB |
NESTLE SA | 1,089,088 14.290% |
1,089,088 (New Position) |
Filing History |
| 2024-04-05 12:21 pm Sale |
2024-03-31 | 13G | Seres Therapeutics, Inc. MCRB |
BlackRock Inc. BLK |
341,270 4.500% |
-25,703 (-7.00%) |
Filing History |
| 2024-02-12 12:23 pm Sale |
2023-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
JANUS HENDERSON GROUP PLC JHG |
24 0.000% |
-562,390 (-100.00%) |
Filing History |
| 2024-02-09 09:49 am Purchase |
2024-02-08 | 13G | Seres Therapeutics, Inc. MCRB |
FMR LLC | 969,429 14.999% |
34,991 (+3.74%) |
Filing History |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
BlackRock Inc. BLK |
366,973 5.700% |
54,518 (+17.45%) |
Filing History |
| 2023-11-07 12:57 pm Sale |
2023-10-31 | 13G | Seres Therapeutics, Inc. MCRB |
FEDERATED HERMES INC. FHI |
258,790 4.040% |
-316,236 (-55.00%) |
Filing History |
| 2023-05-10 10:16 am Sale |
2023-04-30 | 13G | Seres Therapeutics, Inc. MCRB |
FEDERATED HERMES INC. FHI |
575,026 9.000% |
-329,271 (-36.41%) |
Filing History |
| 2023-04-06 09:29 am Sale |
2023-03-31 | 13G | Seres Therapeutics, Inc. MCRB |
BlackRock Inc. BLK |
312,454 5.000% |
-10,494 (-3.25%) |
Filing History |
| 2023-02-10 11:46 am Purchase |
2022-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
JANUS HENDERSON GROUP PLC JHG |
562,415 9.000% |
309,660 (+122.51%) |
Filing History |
| 2023-02-09 12:31 pm Purchase |
2023-02-09 | 13G | Seres Therapeutics, Inc. MCRB |
FMR LLC | 934,438 14.999% |
245,585 (+35.65%) |
Filing History |
| 2023-02-09 11:32 am Purchase |
2022-12-30 | 13G | Seres Therapeutics, Inc. MCRB |
The Vanguard Group | 304,647 4.890% |
70,834 (+30.29%) |
Filing History |
| 2023-02-03 3:19 pm Sale |
2022-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
STATE STREET CORP STT |
228,207 3.660% |
-11,073 (-4.63%) |
Filing History |
| 2023-02-03 12:10 pm Purchase |
2022-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
BlackRock Inc. BLK |
322,949 5.200% |
29,231 (+9.95%) |
Filing History |
| 2023-02-01 12:15 pm Purchase |
2022-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
FEDERATED HERMES INC. FHI |
904,297 14.520% |
5,184 (+0.58%) |
Filing History |
| 2022-08-09 4:02 pm Purchase |
2022-07-31 | 13G | Seres Therapeutics, Inc. MCRB |
BlackRock Inc. BLK |
293,718 4.700% |
583 (+0.20%) |
Filing History |
| 2022-07-22 1:34 pm Sale |
2022-07-18 | 13D | Seres Therapeutics, Inc. MCRB |
Nestle Health Science US Holdings Inc. | 379,702 6.100% |
-14,943 (-3.79%) |
Filing History |
| 2022-07-11 2:13 pm Purchase |
2022-06-30 | 13G | Seres Therapeutics, Inc. MCRB |
FEDERATED HERMES INC. FHI |
899,113 14.500% |
553,406 (+160.08%) |
Filing History |
| 2022-07-07 5:00 pm Purchase |
2022-07-05 | 13D | Seres Therapeutics, Inc. MCRB |
Flagship VentureLabs IV LLC | 1,174,653 18.900% |
422,154 (+56.10%) |
Filing History |